Proteas Bioanalytics Inc. — Form D/A
Proteas Bioanalytics Inc. of Torrance, CA, a company, filed a Form D amendment with the SEC on 2021-11-10. The offering totals $4.0M, of which $1.4M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-11-10
- Form: D/A
- Accession: 0001831825-21-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.4M
- Remaining: $2.6M
- Investors: 7
- Date of first sale: 2020-10-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-380094
Issuer
- Name: Proteas Bioanalytics Inc.
- CIK: 0001831825
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: Biolabs at the Lundquist Institute, Torrance, CA, 90502
- Phone: 626-200-7238
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Spiros D Garbis | Director | Torrance, CA |
| Keith B Hoffman | Director | Torrance, CA |
| Dimitrios D Iliopoulos | Director | Torrance, CA |
| Spiros D Garbis | Executive Officer | Torrance, CA |
| Valerie Darling | Director | Torrance, CA |
| Spiros Garbis | Director | Torrance, CA |
| Spiros Garbis | Executive Officer | Torrance, CA |
| Antigoni Manousopoulou | Director | Torrance, CA |
Other filings by this issuer (2)
More